Continuous advancements in biotechnology are improving the development and manufacturing of erythropoietin products. Pharmaceutical companies are focusing on enhancing product quality, manufacturing efficiency, and treatment accessibility. Market Overview The Erythropoietin Drug Market was valued at US$ 13.14 billion in 2025 and is projected to reach US$ 29.00 billion by 2034, registering a...